| GTO ID | GTC1559 |
| Trial ID | NCT02580747 |
| Disease | Triple-Receptor Negative Breast Cancer | Malignant Mesothelioma | Endometrial Cancer | Pancreatic Cancer |
| Altered gene | MESO |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | MESO CAR-T cells |
| Generation | 2nd |
| Phase | Phase1 |
| Recruitment status | Unknown |
| Title | Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso |
| Year | 2015 |
| Country | China |
| Company sponsor | Chinese PLA General Hospital |
| Other ID(s) | s2015-080-06 |
| Vector information | |||||
|
|||||
| Cohort 1 | |||||||||
|
|||||||||